Inflammation and descending thoracic aortic calcification as detected by computed tomography: The Multi-Ethnic Study of Atherosclerosis

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 201-206

  Takasu, Junichiro ^a   Katz, Ronit ^b   Shavelle, David M ^a   O'Brien, Kevin ^b   Mao, SongShou ^a   Carr, J Jeffrey ^c   Cushman, Mary ^d   Budoff, Matthew J ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiac CT; Coronary calcium; Inflammation; Thoracic calcification

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CALCIFICATION; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DESCENDING THORACIC AORTIC CALCIFICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; AORTA, THORACIC; ASIAN AMERICANS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCINOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 45549100395     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.005     Document Type: Article

References (38)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Kuller L.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 144 (1996) 537-547
3. Pearson T.A., Mensah G.A., Alexander R.W., et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
4. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
5. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
6. Koenig W., Sund M., Frohlich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
7. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
8. Lowe G.D., Rumley A., McMahon A.D., et al., West of Scotland Coronary Prevention Study Group. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 24 (2004) 1529-1534
9. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 15 (2000) 1767-1772
10. Sattar N., Murray H.M., McConnachie A., et al., PROSPER Study Group. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115 8 (2007) 981-989
11. Tintut Y., and Demer L.L. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12 (2001) 555-560
12. Budoff M.J., Achenbach S., Blumenthal R.S., et al. American Heart Association Committee on Cardiovascular Imaging and Intervention; American Heart Association Council on Cardiovascular Radiology and Intervention; American Heart Association Committee on Cardiac Imaging, Council on Clinical Cardiology. Assessment of coronary artery disease by cardiac computed tomography, A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 16 (2006) 1761-1791
13. Park R., Detrano R., Xiang M., et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106 16 (2002) 2073-2077
14. Wang T.J., Larson M.G., Levy D., et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 106 10 (2002) 1189-1191
15. Witteman J.C., Kannel W.B., Wolf P.A., et al. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 66 (1990) 1060-1064
16. Witteman J.C., Kok F.J., van Saase J.L., and Valkenburg H.A. Aortic calcification as a predictor of cardiovascular mortality. Lancet 2 (1986) 1120-1122
17. Hollander M., Hak A.E., Koudstaal P.J., et al. Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 34 (2003) 2367-2372
18. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
19. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
20. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234 (2005) 35-43
21. Budoff M.J., Takasu J., Katz R., et al. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the Multi-Ethnic Study of Atherosclerosis. Acad Radiol 13 (2006) 166-172
22. Takasu J., Budoff M.J., Carr J.J., et al. Relationships of aortic wall calcification to cardiovascular risk factors: the Multi-Ethnic Study of. J Cardiovasc CT (2007) 1
23. Nasir K, Katz R, Takasu J, et al. Ethnic differences between extra-coronary measures on cardiac computed tomography. Atherosclerosis 2007 Oct 19 [Epub ahead of print].
24. Sun H., Koike T., Ichikawa T., et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 167 (2005) 1139-1148
25. Singh U., Devaraj S., and Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 25 (2005) 2216-2221
26. Reifenberg K., Lehr H.A., Baskal D., et al. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?. Arterioscler Thromb Vasc Biol 25 (2005) 1641-1646
27. Baumann H., and Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7 (1990) 147-159
28. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
29. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112 (2005) 976-983
30. Zakai N.A., Katz R., Jenny N.S., et al. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the cardiovascular health study. J Thromb Haemost 5 (2007) 1-8
31. de Beer F.C., Soutar A.K., Baltz M.L., et al. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 156 (1982) 230-242
32. Shavelle DM, Takasu J, Lima J, et al. Inflammation and aortic valve calcification as detected by electron beam computed tomography-the Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging; in press.
33. Bostrom K., Watson K.E., Horn S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91 (1993) 1800-1809
34. Parhami F., Tintut Y., Ballard A., Fogelman A.M., and Demer L.L. Leptin enhances the calcification of vascular cells artery wall as a target of leptin. Circ Res 88 (2001) 954-960
35. Shao B., Bergt C., Fu X., et al. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 280 7 (2005) 5983-5993
36. Lakoski S.G., Cushman M., Palmas W., et al. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 46 (2005) 1869-1874
37. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 22 (1999) 2131-2135
38. Zieske A.W., Tracy R.P., McMahan C.A., et al. Pathobiological Determinants of Atherosclerosis in Youth Research Group. Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol 25 (2005) 1237-1243